<DOC>
	<DOCNO>NCT00705107</DOCNO>
	<brief_summary>Adherence prescribe treatment regimen PegIntron Rebetol affect chance achieve sustain virologic response patient hepatitis C. The objective study evaluate proportion patient complete treatment PegIntron pen Rebetol participate patient assistance program . The patient assistance program consist prophylactic treatment ( eg , growth factor , psychiatric medication ) intervention ( eg , psychotherapy , patient support group , visit nurse , nurse telephone call , educational literature ) .</brief_summary>
	<brief_title>Adherence Treatment With PegIntron Pen Plus Rebetol Treatment-naïve Adult Patients With Hepatitis C Romania ( Study P04247 )</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<mesh_term>Peginterferon alfa-2b</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<criteria>Treatmentnaïve patient hepatitis C Patients treat PegIntron pen Rebetol Patients receive patient assistance program</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>